The binding site and regulatory mechanisms of the C-MYC/NCOA4 axis in ovarian cancer cells have not been fully clarified; we plan to expound on this point through exploration of the molecular mechanisms of NCOA4 mRNA transcription in the future. This evidence concerns the gene MYC and ovarian cancer.